ISSN 1016-5169 | E-ISSN 1308-4488
The impact of dialysis type on biomarkers for cardiovascular diseases [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2011; 39(6): 456-462 | DOI: 10.5543/tkda.2011.01289

The impact of dialysis type on biomarkers for cardiovascular diseases

Asife Şahinarslan1, Galip Güz2, Rüya Mutluay2, Kaan Okyay1, Canan Demirtaş3, Hatice Paşaoğlu3, Rıdvan Yalçın1
1Gazi University, School of Medicine, Department of Cardiology, Ankara, Turkey
2Gazi University, School of Medicine, Department of Nephrology, Ankara, Turkey
3Gazi University, School of Medicine, Department of Biochemistry, Ankara, Turkey


OBJECTIVES
The impact of dialysis type on the biomarkers that reflect the severity of cardiovascular diseases is not clearly known. We aimed to investigate the effect of dialysis type on biomarkers of cardiovascular diseases in patients with end-stage renal disease (ESRD).

STUDY DESIGN
The study included 108 patients who had been on dialysis treatment (57 patients receiving hemodialysis, 51 patients receiving peritoneal dialysis) for ESRD for at least three months. Blood samples were collected just after the dialysis. Serum N-terminal prohormone of brain natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP), cardiac troponin I (TnI), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and plasma fibrinogen levels were measured and compared between the two dialysis groups.

RESULTS
The two dialysis groups were similar with respect to age and gender. The frequency of hypertension was significantly higher in patients receiving peritoneal dialysis. This group also had higher total cholesterol, HDL cholesterol, LDL cholesterol, and hemoglobin levels. Serum levels of NT-proBNP, hs-CRP, IL-6, and TNF-α, and plasma fibrinogen levels were similar in the two dialysis groups (p>0.05), but TnI was significantly higher in patients receiving peritoneal dialysis (p=0.04). Comparison of the patient subgroups based on the duration of dialysis (<12 months, 12-36 months, and >36 months) showed that longer dialysis duration was associated with significantly lower values of NT-proBNP, TNF-α, and hs-CRP (p<0.05).

CONCLUSION
The dialysis type does not affect serum NT-proBNP, hs-CRP, IL-6, TNF-α, and plasma fibrinogen levels, but TnI level is higher in patients treated with peritoneal dialysis.

Keywords: Biological markers, cardiovascular diseases, dialysis/adverse effects; kidney failure, chronic/complications

Corresponding Author: Asife Şahinarslan, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.